Ulrike Gnad-Vogt

Technik-/Wissenschafts-/F&E-Leiter bei CureVac SE

Health Technology

Consumer Services

Aktive Positionen von Ulrike Gnad-Vogt

Unternehmen	Position	Beginn	Ende
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2011	-

Unternehmen	Position	Beginn	Ende
CUREVAC N.V.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2011	01.01.2019
CUREVAC N.V.	Corporate Officer/Principal	01.01.2019	-

Universität des Saarlandes

Doctorate Degree

International

Deutschland

Operativ

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
CUREVAC N.V.	Health Technology

Private Unternehmen	1
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Health Technology

Private Unternehmen

Health Technology